NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Major histocompatibility complex (MHC) molecules are expressed on the cell surface, where they present peptides to T cells, which gives them a key role in the development of T-cell immune responses. MHC molecules come in two main variants: MHC Class I (MHC-I) and MHC Class II (MHC-II). MHC-I predominantly present peptides derived from intracellular proteins, whereas MHC-II predominantly presents peptides from extracellular proteins. In both cases, the binding between MHC and antigenic peptides is the most selective step in the antigen presentation pathway. Therefore, the prediction of peptide binding to MHC is a powerful utility to predict the possible specificity of a T-cell immune response. Commonly MHC binding prediction tools are trained on binding affinity or mass spectrometry-eluted ligands. Recent studies have however demonstrated how the integration of both data types can boost predictive performances. Inspired by this, we here present NetMHCpan-4.1 and NetMHCIIpan-4.0, two web servers created to predict binding between peptides and MHC-I and MHC-II, respectively. Both methods exploit tailored machine learning strategies to integrate different training data types, resulting in state-of-the-art performance and outperforming their competitors. The servers are available at http://www.cbs.dtu.dk/services/NetMHCpan-4.1/ and http://www.cbs.dtu.dk/services/NetMHCIIpan-4.0/.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Among these tools, NetMHCpan stands out in predicting the binding affinity between peptides and MHC-I/II, respectively [139].”
From Single-cell sequencing to multi-omics: technologies and applications (2024) · cites this paper as [139]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jurtz, V., Paul, S., Andreatta, M., Marcatili, P., Peters, B., & Nielsen, M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700893 · Cited by 1,470
Self-citationImproved methods for predicting peptide binding affinity to MHC class II molecules
Jensen, K. K., Andreatta, M., Marcatili, P., Buus, S., Greenbaum, J. A., Yan, Z., Sette, A., Peters, B., & Nielsen, M. (2018) · Immunology · doi:10.1111/imm.12889 · Cited by 794
Self-citationAbelin, J. G., Keskin, D. B., Sarkizova, S., Hartigan, C. R., Zhang, W., Sidney, J., Stevens, J., Lane, W., Zhang, G. L., Eisenhaure, T. M., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.02.007 · Cited by 617
Nielsen, M., & Andreatta, M. (2016) · Genome Medicine · doi:10.1186/s13073-016-0288-x · Cited by 517
Self-citationSarkizova, S., Klaeger, S., Le, P. M., Li, L. W., Oliveira, G., Keshishian, H., Hartigan, C. R., Zhang, W., Braun, D. A., Ligon, K. L., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-019-0322-9 · Cited by 499
Reynisson, B., Barra, C., Kaabinejadian, S., Hildebrand, W. H., Peters, B., & Nielsen, M. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00874 · Cited by 445
Self-citationMHCflurry: Open-Source Class I MHC Binding Affinity Prediction
O'Donnell, T. J., Rubinsteyn, A., Bonsack, M., Riemer, A. B., Laserson, U., & Hammerbacher, J. (2018) · Cell Systems · doi:10.1016/j.cels.2018.05.014 · Cited by 409
Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification
Bulik-Sullivan, B., Busby, J., Palmer, C. D., Davis, M. J., Murphy, T., Clark, A., Busby, M., Duke, F., Yang, A., Young, L., et al. (2019) · Nature Biotechnology · doi:10.1038/nbt.4313 · Cited by 307
Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes
Racle, J., Michaux, J., Rockinger, G. A., Arnaud, M., Bobisse, S., Chong, C., Guillaume, P., Coukos, G., Harari, A., Jandus, C., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0289-6 · Cited by 289
Karosiene, E., Rasmussen, M., Blicher, T., Lund, O., Buus, S., & Nielsen, M. (2013) · Immunogenetics · doi:10.1007/s00251-013-0720-y · Cited by 272
Self-citation
Research works printed but not linked: 1
- O’Donnell T.J., Rubinsteyn A., Bonsack M., Riemer A.B., Laserson U., Hammerbacher J. 2020; MHCFlurry https://github.com/openvax/mhcflurry. 29960884
Cited by
Items 801–900 of 1,014
Thongchot, S., Aksonnam, K., Prasopsiri, J., Warnnissorn, M., Sa-nguanraksa, D., O‐charoenrat, P., Thuwajit, P., Yenchitsomanus, P., & Thuwajit, C. (2024) · BMC Medicine · doi:10.1186/s12916-024-03625-3 · Cited by 11
Abbar, B., Labrèche, K., Cadranel, J. L., Veyri, M., Morin, V., Thiam, F. S., Désiré, N., Baron, M., Guillerm, E., Perrier, A., et al. (2025) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2025.02.001 · Cited by 11
Giri-Rachman, E. A., Kurnianti, A. M. F., Rizarullah, R., Setyadi, A. H., Artarini, A., Tan, M. I., Riani, C., Natalia, D., Aditama, R., & Nugrahapraja, H. (2025) · Journal of Genetic Engineering and Biotechnology · doi:10.1016/j.jgeb.2025.100524 · Cited by 11
McGowan, E., Rosenthal, R., Fiore-Gartland, A. J., Macharia, G. N., Balinda, S. N., Kapaata, A. A., Umviligihozo, G., Muok, E. M. O., Dalel, J. A., Streatfield, C., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.609884 · Cited by 11
Self-citationBehera, S. K., Thankappan, S., Mishra, P. K. K., Deneke, Y., Kumar, A., ChandraSekar, S., Senthilkumar, K., Verma, M. R., Ganesh, B., Gurav, A. R., et al. (2021) · Pathogens · doi:10.3390/pathogens10091082 · Cited by 11
A Novel Proteogenomic Integration Strategy Expands the Breadth of Neo-Epitope Sources
Xiang, H., Zhang, L., Bu, F., Guan, X., Chen, L., Zhang, H., Zhao, Y., Chen, H., Zhang, W., Li, Y., et al. (2022) · Cancers · doi:10.3390/cancers14123016 · Cited by 11
Nelde, A., Rieth, J., Roerden, M., Dubbelaar, M. L., Gravel, N. H., Bauer, J., Klein, R., Hoheisel, T., Mahrhofer, H., Göpel, S., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105643 · Cited by 11
Improvement of Neoantigen Identification Through Convolution Neural Network
Hao, Q., Wei, P., Shu, Y., Zhang, Y., Xu, H., & Zhao, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.682103 · Cited by 11
Bioinformatics Prediction of SARS-CoV-2 Epitopes as Vaccine Candidates for the Colombian Population
Montes‐Grajales, D., & Olivero‐Verbel, J. (2021) · Vaccines · doi:10.3390/vaccines9070797 · Cited by 11
AIRIVA: A Deep Generative Model of Adaptive Immune RepertoiresPreprint
Pradier, M. F., Prasad, N., Chapfuwa, P., Ghalebikesabi, S., Ilse, M., Woodhouse, S., Elyanow, R., Zazo, J., Gonzalez, J., Greissl, J., et al. (2023) · arXiv (Cornell University) · doi:10.48550/arxiv.2304.13737 · Cited by 11
TransHLA: a Hybrid Transformer model for HLA-presented epitope detection
Lu, T., Wang, X., Nie, W., Huo, M., & Li, S. (2025) · GigaScience · doi:10.1093/gigascience/giaf008 · Cited by 10
Silva, M. F., Pereira, G., Mateus, L. M., Lopes-da-Costa, L., & Silva, E. (2024) · BMC Veterinary Research · doi:10.1186/s12917-024-04006-x · Cited by 10
Yaseen, A. R., Suleman, M., Jabeen, A., Nezami, L., Qadri, A. S., Arif, A., Arshad, I., Iqbal, K., Yaqoob, T., & Khan, Z. (2024) · Biologicals · doi:10.1016/j.biologicals.2024.101770 · Cited by 10
Harnessing microbial antigens as cancer antigens: a promising avenue for cancer immunotherapy
Zhang, T., Zhang, X., Chen, J., Zhang, X., & Zhang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1411490 · Cited by 10
Design, Development and Immunogenicity Study of a Multi-Epitope Vaccine Prototype Against SARS-CoV-2
Atanasova, M., Dimitrov, I., Ralchev, N., Markovski, A. M., Manoylov, I. K., Bradyanova, S. L., Mihaylova, N., Tchorbanov, A. I., & Doytchinova, I. A. (2024) · Pharmaceuticals · doi:10.3390/ph17111498 · Cited by 10
Hare, J., Nielsen, M., Kiragga, A. N., & Ochiel, D. O. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1499079 · Cited by 10
Self-citationPan‐Variant SARS‐CoV‐2 Vaccines Induce Protective Immunity by Targeting Conserved Epitopes
Shah, M., Moon, S. U., Shin, J., Choi, J. H., Kim, D., & Woo, H. G. (2025) · Advanced Science · doi:10.1002/advs.202409919 · Cited by 10
Assoni, L., Valim, V., Couto, A. J. M., Trentini, M. M., Gonçalves, V. M., Ferraz, L. F. C., Sciani, J. M., Cremonesi, A. S., Converso, T. R., de Carvalho, L. M., et al. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127075 · Cited by 10
Strategies for neoantigen screening and immunogenicity validation in cancer immunotherapy (Review)
Feng, H., Jin, Y., & Wu, B. (2025) · International Journal of Oncology · doi:10.3892/ijo.2025.5749 · Cited by 10
Chundru, D., Bhattrai, S., Timilsina, M., Lillehoj, H. S., Sun, Z., Ghanem, M., & Li, Z. (2025) · Microorganisms · doi:10.3390/microorganisms13051147 · Cited by 10
Computational vaccine development against protozoa
Hashim, O., & Dimier‐Poisson, I. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2025.06.011 · Cited by 10
Artificial intelligence in therapeutic antibody design: Advances and future prospects
Park, S., Jeong, W., Kim, Y., Lee, C., & Seok, C. (2025) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2025.103084 · Cited by 10
Deciphering the MHC immunopeptidome of human cancers with Ligand.MHC atlas
Ran, Z., Mu, M., Lin, S., Wang, T., Zeng, J., Kuang, L., Chen, K., Suo, S., Yuan, K., & Xu, H. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf314 · Cited by 10
Artificial Intelligence in Hematopoietic Stem Cell Transplantation Care and Complication Management
Turki, A. T., Mussetti, A., Scheidler, K. M., Kehrmann, J., Crivello, P., Hosch, R., Nensa, F., & Polizzi, S. (2025) · Acta Haematologica · doi:10.1159/000547767 · Cited by 10
Elavarasu, S. M., & Sasikumar, K. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1617251 · Cited by 10
Multiomics approach to evaluating personalized biomarkers of allergen immunotherapy
Shamji, M. H., Fulton, W. T., Animashaun, I., Palmer, E., Baerenfaller, K., Sokołowska, M., Barber, D., Huffaker, M. F., Baloh, C., Pfaar, O., et al. (2025) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2025.06.036 · Cited by 10
Immunologic specificity in glioblastoma: Antigen discovery and translational implications
Hill, C. M., Wang, A. Z., Hsueh, B., Ramirez, R., Sherpa, N. D., Costa, M. A., Williams, O., Mao, L., & Dunn, G. P. (2025) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaf028 · Cited by 10
Mashrur, M. N., Imranuzzaman, M., Barua, H., Hasan, M. R., Hridy, F. K., Sakib, T. S., Rani, N. A., Rahman, M., Ahsan, G., Ashraf, T., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-26139-1 · Cited by 10
Harnessing deep learning to accelerate the development of antibodies and aptamers
Tan, P., Li, S., Huang, J., Zhou, Z.-Y., & Hong, L. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.12.017 · Cited by 10
Zhang, M., Ali, S. L., Tian, Y., Abduldayeva, A. A., Zhou, S., An, Y., Li, Y., Ni, R., Zhang, L., Liu, Y., et al. (2025) · Bioengineering · doi:10.3390/bioengineering12121378 · Cited by 10
EBV strain interacts with host HLA to drive nasopharyngeal carcinoma risk
Chen, Y., Liang, J., Zhang, W., Zhang, X., Zhang, X., Wang, C., Yao, F., Zhang, S., Zhou, X., Ye, W., et al. (2026) · Nature · doi:10.1038/s41586-026-10416-8 · Cited by 10
Burq, M., Štepec, D., Restrepo, J., Žbontar, J., Urazbakhtin, S. Z., Crampton, B., Tiwary, S., Chinoy, R., Miao, M., Cox, J., et al. (2026) · Journal of Molecular Biology · doi:10.1016/j.jmb.2026.169940 · Cited by 10
Dang, T. T. T., Anzurez, A., Nakayama‐Hosoya, K., Miki, S., Yamashita, K., de Souza, M. S., Matano, T., & Kawana‐Tachikawa, A. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.02143-23 · Cited by 10
Panya, A., Thepmalee, C., Sawasdee, N., Saengmuang, S., Luangwattananun, P., & Yenchitsomanus, P. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115827 · Cited by 10
Kupani, M., Pandey, R. K., Vashisht, S., Singh, S., Prajapati, V. K., & Mehrotra, S. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22121 · Cited by 10
Gomes, J. G. D. S., Brandão, L. C., Pinheiro, D. P., Pontes, L. Q., Carneiro, R. F., Quintela, B. C. S. F., Marinho, A. C. M., Furtado, G. P., & Rocha, B. A. M. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.133731 · Cited by 10
Shah, M., Sitara, F., Sarfraz, A., Shehroz, M., Wara, T. U., Perveen, A., Ullah, N., Zaman, A., Nishan, U., Ahmed, S., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1281544 · Cited by 10
Oladipo, E. K., Ojo, T. O., Elegbeleye, O. E., Bolaji, O. Q., Oyewole, M. P., Ogunlana, A. T., Olalekan, E. O., Bamidele, A., Adediran, D. A., Obideyi, O. A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-66828-x · Cited by 10
In silico designing of multi-epitope vaccine against canine parvovirus using reverse vaccinology
Lopes, T. S., Gheno, B. P., Miranda, L. D. S., Detofano, J., Khan, M. A. A., & Streck, A. F. (2024) · Brazilian Journal of Microbiology · doi:10.1007/s42770-024-01442-7 · Cited by 10
Peptide Vaccine Design by Evolutionary Multi-Objective Optimization
Liu, D., Xu, Y.-H., & Qian, C. (2024) · International Joint Conference on Artificial Intelligence · doi:10.24963/ijcai.2024/770 · Cited by 10
Samantaray, M., Pushan, S. S., Rajagopalan, M., Abrol, K., Basumatari, J., Murthy, T. P. K., & Ramaswamy, A. (2025) · Molecular Diversity · doi:10.1007/s11030-025-11124-7 · Cited by 10
Unveiling conserved HIV-1 open reading frames encoding T cell antigens using ribosome profiling
Bertrand, L., Nelde, A., Ramírez, B. C., Hatin, I., Arbès, H., François, P., Demais, S., Labaronne, E., Décimo, D., Guiguettaz, L., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56773-2 · Cited by 10
Zaher, M. R., El-Husseiny, M. H., Hagag, N. M., Elamir, A. M., Zowalaty, M. E. E., & Tammam, R. H. (2025) · BMC Veterinary Research · doi:10.1186/s12917-025-04509-1 · Cited by 10
VaccineDesigner: A Web-Based Tool for Streamlined Multi-Epitope Vaccine Design
Trygoniaris, D., Korda, A., Paraskeva, A., Dushku, E., Tzimagiorgis, G., Yiangou, M., Kotzamanidis, C., & Malousi, A. (2025) · Biology · doi:10.3390/biology14081019 · Cited by 10
Ghosh, N., Sharma, N., & Saha, I. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.104823 · Cited by 10
Joyce, S., & Ternette, N. (2021) · PROTEOMICS · doi:10.1002/pmic.202000143 · Cited by 10
Toward Guided Mutagenesis: Gaussian Process Regression Predicts MHC Class II Antigen Mutant Binding
Bell, D. R., & Chen, S. H. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c00458 · Cited by 10
Statins mediate anti- and pro-tumourigenic functions by remodelling the tumour microenvironment
Kamata, T., Aldujaily, E., Alhamad, S., So, T. Y., Margaritaki, O., Giblett, S. M., Pringle, J. H., Quesne, J. P. C. L., & Pritchard, C. A. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049148 · Cited by 11
Charneau, J., Suzuki, T., Shimomura, M., Fujinami, N., Mishima, Y., Hiranuka, K., Watanabe, N., Yamada, T., Nakamura, N., & Nakatsura, T. (2022) · Cancer Science · doi:10.1111/cas.15291 · Cited by 10
Nasar, S., Nasar, Z., & Iftikhar, S. (2022) · Microbial Pathogenesis · doi:10.1016/j.micpath.2022.105447 · Cited by 10
Progress in kidney transplantation: The role for systems immunology
Johnson, A. C., Silva, J. A. F., Kim, S. C., & Larsen, C. P. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1070385 · Cited by 10
Immunolyser: A web-based computational pipeline for analysing and mining immunopeptidomic data
Munday, P. R., Fehring, J., Revote, J., Pandey, K., Shahbazy, M., Scull, K. E., Ramarathinam, S. H., Faridi, P., Croft, N. P., Braun, A., et al. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.02.033 · Cited by 10
Activation of Human CD8+ T Cells with Nitroso Dapsone–Modified HLA-B*13:01–Binding Peptides
Almutairi, M., Lister, A., Zhao, Q. S., Line, J., Adair, K., Tailor, A., Waddington, J. C., Clarke, E., Gardner, J., Thomson, P., et al. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200531 · Cited by 10
Abdelaziz, M. O., Raftery, M. J., Weihs, J., Bielawski, O., Edel, R., Köppke, J. K. C., Vladimirova, D., Adler, J. M., Firsching, T. C., Voß, A., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1166765 · Cited by 10
Toribio, L. M., Guzman, C., Noazin, S., Zimic-Sheen, A., Zimic, M., Gonzáles, I., Saavedra, H., Pretell, E. J., Bustos, J. A., Handali, S., et al. (2023) · Journal of Clinical Microbiology · doi:10.1128/jcm.00760-23 · Cited by 10
Structure prediction of novel isoforms from uveal melanoma by AlphaFold
Zhang, Z., Li, C., Li, Q., Su, X.-M., Li, J., Zhu, L., Lin, X. J., & Shen, J. (2023) · Scientific Data · doi:10.1038/s41597-023-02429-z · Cited by 10
Deciphering the landscape of phosphorylated HLA-II ligands
Solleder, M., Racle, J., Guillaume, P., Coukos, G., Bassani-Sternberg, M., & Gfeller, D. (2022) · iScience · doi:10.1016/j.isci.2022.104215 · Cited by 9
Immunoinformatics: an interdisciplinary technique for designing and engineering vaccine antigen
Manvani, R., Purohit, H., Sahoo, C. R., Rajput, M., & Shah, S. H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13395-4.00012-5 · Cited by 9
Jian, F., Cai, H., Chen, Q., Pan, X., Feng, W., & Yuan, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1550252 · Cited by 9
Najera, S. S., Nicastri, A., Bing, S. J., Sajib, A. M., Ternette, N., & Mazor, R. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101506 · Cited by 9
Shi, Q., Simon, E. P., Bozkus, C. C., Kaminska, A., Velazquez, L. G., Saxena, M., Zhang, Z., Belk, J. A., Wang, S., Yang, N., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02268-1 · Cited by 9
Aaen, K. H., Testa, M. F., Nilsen, J., Tarantino, R., Canepari, C., Benedusi, M., Benjakul, S., Nyquist-Andersen, M., Herigstad, M. L., Cantore, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62955-9 · Cited by 9
Karle, A. C., Kopp, K. L., Seward, R., Tourdot, S., Ackaert, C., Gutknecht, M. F., Cloake, E. A., Smith, N., & Ducret, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1690101 · Cited by 9
Quantitative and large-scale investigation of human TCR-HLA cross-reactivity
Pan, M., Tan, Y., Wang, Y. T., Hu, J. R., Fleming, J., Hu, H., Yang, Z., Zhan, X., & Li, B. (2025) · Science Advances · doi:10.1126/sciadv.adx1751 · Cited by 9
Autoimmunity, epitope analysis, and molecular mimicry
Rojas, M., Acosta‐Ampudia, Y., Monsalve, D. M., Ramírez-Santana, C., Heuer, L. S., Ridgway, W. M., Anaya, J., Lian, Z.-X., & Gershwin, M. E. (2025) · Current Opinion in Immunology · doi:10.1016/j.coi.2025.102681 · Cited by 9
T-SCAPE: T cell immunogenicity scoring via cross-domain aided predictive engine
Kim, J., Jung, N., Lee, J. Y., Cho, N., Noh, J., & Seok, C. (2025) · Science Advances · doi:10.1126/sciadv.adz8759 · Cited by 10
Immunopeptidomics combined with full-length transcriptomics uncovers diverse neoantigens
Ishino, T., Watanabe, T., Tokita, S., Ueda, Y., Kawase, K., Takano, Y., Thu, Y. M., Suzuki, Y., Owa, C., Inozume, T., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116781 · Cited by 9
Tan, T., Diao, Y., Yu, X., Chen, L., & Fang, H. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.12.044 · Cited by 9
Naveed, M., Asim, M., Aziz, T. A., Athar, A., Majeed, M. N., Tombozara, N., Al-Zaban, M. I., Shami, A., Alwethaynani, M. S., & Al‐Joufi, F. A. (2026) · Scientific Reports · doi:10.1038/s41598-026-36680-2 · Cited by 9
Hidden Targets in Cancer Immunotherapy: The Potential of “Dark Matter” Neoantigens
Rwandamuriye, F. X., Redwood, A., Creaney, J., & Robinson, B. W. S. (2026) · Vaccines · doi:10.3390/vaccines14010104 · Cited by 9
Asim, M., Naveed, M., Aziz, T., Toheed, M., Rehman, H. M., Al‐Hoshani, N., Mohamed, R. A. E. H., Alwethaynani, M. S., Alhhazmi, A. A., & Elkhadragy, M. F. (2026) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-026-05022-9 · Cited by 9
SIGANEO: Similarity network with GAN enhancement for immunogenic neoepitope prediction
Ye, Y., Shen, Y., Wang, J., Li, D., Zhu, Y., Zhao, Z., Pan, Y., Wang, Y., Liu, X., & Wan, J. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.10.050 · Cited by 9
Jung, E. S., Ellinghaus, D., Degenhardt, F. C., Meguro, A., Khor, S., Mucha, S., Wendorff, M., Juzėnas, S., Mizuki, N., Tokunaga, K., et al. (2023) · Digestive and Liver Disease · doi:10.1016/j.dld.2023.10.021 · Cited by 9
Amos, E. O., Araoyinbo, O. S., Akinleye, E. O., Alakanse, S. O., Afolabi, O. B., & Kolawole, O. M. (2023) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2023.101411 · Cited by 9
In Silico Immunogenicity Assessment of Therapeutic Peptides
Li, W., Wei, J., Jiang, Q., Zhou, Y., Yan, X., Xiang, C., & Huang, J. H. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673264899231206093930 · Cited by 9
The electrostatic landscape of MHC-peptide binding revealed using inception networks
Wilson, E., Cava, J. K., Chowell, D., Raja, R., Mangalaparthi, K. K., Pandey, A., Curtis, M., Anderson, K. S., & Singharoy, A. (2024) · Cell Systems · doi:10.1016/j.cels.2024.03.001 · Cited by 9
Maina, M., Musundi, S., Kuja, J., Waweru, H., Kiboi, D. M., Kanoi, B. N., & Gitaka, J. (2024) · Frontiers in Parasitology · doi:10.3389/fpara.2024.1346017 · Cited by 9
Mösch, A., Grazioli, F., Machart, P., & Malone, B. (2024) · Bioinformatics · doi:10.1093/bioinformatics/btae205 · Cited by 9
Advances in Therapeutic Cancer Vaccines, Their Obstacles, and Prospects Toward Tumor Immunotherapy
Eskandari, A., Leow, T. C., Rahman, M. B. A., & Oslan, S. N. (2024) · Molecular Biotechnology · doi:10.1007/s12033-024-01144-3 · Cited by 9
Naidoo, L., Arumugam, T., & Ramsuran, V. (2024) · Infectious Disease Reports · doi:10.3390/idr16020029 · Cited by 9
Ghafouri, E., Fadaie, M., Amirkhani, Z., Esmaeilifallah, M., Rahimmanesh, I., Hosseini, N. S., Hejazi, S. H., & Khanahmad, H. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112160 · Cited by 9
Kawase, K., Taguchi, A., Ishizaka, A., Lin, J. C., Ueno, T., Yoshimoto, D., Eguchi, S., Mori, S., Sone, K., Mori, M., et al. (2024) · HLA · doi:10.1111/tan.15509 · Cited by 9
Chen, Y., Xinqi, S., Chen, W., Zhao, X., Li, Y., & Liu, D. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1402963 · Cited by 9
Han, Z., Mai, Q., Zhao, Y., Liu, X., Cui, M., Li, M., Chen, Y.-Q., Shu, Y., Gan, J., Pan, W., et al. (2024) · Antiviral Research · doi:10.1016/j.antiviral.2024.105978 · Cited by 9
Jonchère, V., Montémont, H., Scanf, E. L., Siret, A., Letourneur, Q., Tubacher, E., Battail, C., Fall, A., Labrèche, K., Renault, V., et al. (2024) · Genome biology · doi:10.1186/s13059-024-03340-5 · Cited by 9
A review of CD4+ T cell differentiation and diversity in dogs
Lang, H. P., Osum, K. C., & Friedenberg, S. G. (2024) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2024.110816 · Cited by 9
Developing Vaccines in Pancreatic Adenocarcinoma: Trials and Tribulations
Phan, T. X., Fan, D., & Melstrom, L. G. (2024) · Current Oncology · doi:10.3390/curroncol31090361 · Cited by 9
Broadening alloselectivity of T cell receptors by structure guided engineering
Karuppiah, V., Sangani, D., Whaley, L. M., Pengelly, R., Uluocak, P., Carreira, R. J., Hock, M., Cristina, P. D., Bartasun, P., Dobrinić, P., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-75140-7 · Cited by 9
Salahlou, R., Farajnia, S., Alizadeh, E., Dastmalchi, S., Bargahi, N., Rahbarnia, L., & Steyar, S. H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e40774 · Cited by 9
Saihar, A., Yaseen, A. R., Suleman, M., Parveen, R., & Bashir, H. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.107171 · Cited by 9
Effective design of therapeutic nanovaccines based on tumor neoantigens
Wang, W., Zhai, Y., Yang, X., Ye, L., Lu, G., Shi, X., & Zhai, G. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.01.078 · Cited by 9
Xu, L., Xie, N., Liu, Y., Tang, H., Li, T. X., Peng, J., & Li, R. (2025) · Immunology · doi:10.1111/imm.13936 · Cited by 9
Bozkus, C. C., Brown, M., Velazquez, L. G., Thomas, M., Wilson, E. A., O’Donnell, T. J., Kaminska, A., Ruchnewitz, D., Geertz, D., Bykov, Y., et al. (2025) · iScience · doi:10.1016/j.isci.2025.113044 · Cited by 9
Piel, L. M. W., Durfee, C. J., & White, S. N. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04181-w · Cited by 9
Kaaijk, P., Emmelot, M. E., Kerkhof, J., van Els, C. A. C. M., Meiring, H. D., de Wit, J., & Bodewes, R. (2021) · Vaccines · doi:10.3390/vaccines9070699 · Cited by 9
The Association of Human Leukocyte Antigen and COVID-19 in Southern China
Yu, X., Ho, K.-T., Shen, Z., Fu, X., Huang, H., Wu, D., Lin, Y., Lin, Y., Chen, W., Su, M., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab410 · Cited by 9
Martín-Galiano, A. J., Díez‐Fuertes, F., McConnell, M. J., & López, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.732693 · Cited by 9
Mohinani, T., Saxena, A., & Singh, S. V. (2021) · Current Genomics · doi:10.2174/1389202922666211129113917 · Cited by 9
Michalik, M., Djahanschiri, B., Leo, J. C., & Linke, D. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1892-9_4 · Cited by 9
The Role of Hydrophobicity in Peptide-MHC Binding
Solanki, A., Riedel, M. D., Cornette, J. L., Udell, J. B. M., Koratkar, I., & Vasmatzis, G. (2021) · Lecture notes in computer science · doi:10.1007/978-3-030-91241-3_3 · Cited by 9
Metadata
- Authors
- Reynisson, B., Alvarez, B., Paul, S., Peters, B., & Nielsen, M.
- Affiliations
- Technical University of Denmark (DK)
- National University of General San Martín (AR)
- La Jolla Institute for Immunology (US)
- Corresponding author
- Nielsen, Morten
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-05-14
- Volume
- 48
- Issue
- W1
- Pages
- W449-W454
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC7319546
- OpenAlex
- W3024570138
- Cited by
- 2,361
- References
- 26
- Citations by year
- 2026: 493 · 2025: 550 · 2024: 459 · 2023: 345 · 2022: 250 · 2021: 216 · 2020: 47
- FWCI
- 69.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion, public-domain)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-sa)
- Funders
- National Institutes of Health (75N93019C00001)
- EIT Health (19638)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Machine Learning in Bioinformatics
- Keywords
- MHC-peptide binding prediction, MHC class I, MHC class II, antigen presentation, NetMHCpan, machine learning, web server, T cell response
- MeSH terms
- Machine Learning, Histocompatibility Antigens Class II, Ligands, Peptides, Software, Histocompatibility Antigens Class I, Antigen Presentation, Amino Acid Motifs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.